ロード中...

Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures

BACKGROUND AND PURPOSE: Perampanel, a selective noncompetitive antagonist at the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, is highly effective in a wide range of experimental models. Although initially licensed as adjunctive therapy for partial seizures with or without se...

詳細記述

保存先:
書誌詳細
出版年:Neuropsychiatr Dis Treat
主要な著者: Besag, Frank MC, Patsalos, Philip N
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876101/
https://ncbi.nlm.nih.gov/pubmed/27274257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S83842
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!